AMERISAFE Balance Sheet Health
Financial Health criteria checks 5/6
AMERISAFE has a total shareholder equity of $301.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.2B and $942.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$72.02m |
| Equity | US$301.09m |
| Total liabilities | US$942.05m |
| Total assets | US$1.24b |
Recent financial health updates
No updates
Recent updates
AMERISAFE (NASDAQ:AMSF) Has Announced A Dividend Of $0.37
Apr 28
AMERISAFE (NASDAQ:AMSF) Is Due To Pay A Dividend Of $0.37
Feb 28AMERISAFE goes ex dividend tomorrow
Sep 07Amerisafe announces Anastasios Omiridis as CFO
Aug 25AMERISAFE GAAP EPS of $0.32, revenue of $68.03M misses by $4.16M
Jul 28Amerisafe After Earnings: An Update - Pessimism Sets It
Mar 10Amerisafe: Get A 12% Return Even If The Business Stagnates
Dec 30If You Like EPS Growth Then Check Out AMERISAFE (NASDAQ:AMSF) Before It's Too Late
Jun 09AMERISAFE, Inc. (NASDAQ:AMSF) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Mar 06Why AMERISAFE, Inc. (NASDAQ:AMSF) Is A Dividend Rockstar
Feb 12
Declining Stock and Decent Financials: Is The Market Wrong About AMERISAFE, Inc. (NASDAQ:AMSF)?
Jan 17How Does AMERISAFE's (NASDAQ:AMSF) CEO Salary Compare to Peers?
Dec 22AMERISAFE's(NASDAQ:AMSF) Share Price Is Down 14% Over The Past Year.
Nov 25AMERISAFE declares $0.27 dividend and $3.50 special dividend
Oct 28Financial Position Analysis
Short Term Liabilities: AMSF's short term assets ($351.8M) exceed its short term liabilities ($168.7M).
Long Term Liabilities: AMSF's short term assets ($351.8M) do not cover its long term liabilities ($773.4M).
Debt to Equity History and Analysis
Debt Level: AMSF is debt free.
Reducing Debt: AMSF has not had any debt for past 5 years.
Debt Coverage: AMSF has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: AMSF has no debt, therefore coverage of interest payments is not a concern.